Jixiang Zhang - Publications
Affiliations: | 2022- | Symptom Research | University of Texas M.D. Anderson Cancer Center |
Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, Kantarjian HM, Ravandi F, Collins ME, Francesco MED, Dumbrava EE, Fu S, Gao S, Gay JP, Gera S, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature Medicine. PMID 36658425 DOI: 10.1038/s41591-022-02103-8 | 0.39 | |||
2022 | Zhang J, Junigan JM, Trinh R, Kavelaars A, Heijnen CJ, Grace PM. HDAC6 inhibition reverses cisplatin-induced mechanical hypersensitivity via tonic delta opioid receptor signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 36096670 DOI: 10.1523/JNEUROSCI.1182-22.2022 | 0.429 | |||
2015 | Li J, Zhang J, Zhang N, Zhang Y, Wu W, Li J. Development of a replicative plasmid for gene expression in Mycoplasma bovis. Journal of Microbiological Methods. 108: 12-8. PMID 25451459 DOI: 10.1016/j.mimet.2014.11.005 | 0.404 | |||
Show low-probability matches. |